Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

https://soho2018.org/

 

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Avatar

T-ALL: Nelarabine In The Frontline; And What To Do About Relapse?

By Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018) FEATURING Daniel J. DeAngelo
By Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018) FEATURING Daniel J. DeAngelo
203 views
October 24, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip
Session IV: Acute Lymphoblastic Leukemia
18:57

MLL Leukemias: A Remaining Hurdle

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

R. Pieters

30 views
21:00

CART T Cells in ALL - CD19, CD22 and Development of Bivalent CAR, Di…

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

T. Fry

300 views
17:59

Combining Molecular Genetics and Cytogenetics for Prognostication

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

H. Dombret

7 views
21:19

Can MRD Monitoring Be Done Using Peripheral Blood?

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

L. Muffly

131 views
17:42

T-ALL: Nelarabine In The Frontline; And What To Do About Relapse?

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

D. DeAngelo

203 views
12:25

Oral Abstract ALL 131: Safety and Efficacy of the BCL Inhibitors Ven…

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

A. Hantel

27 views